Advertisement
Research Article| Volume 25, ISSUE 8, P989-1002, April 15, 1989

Download started.

Ok

The significance of HPA axis disturbance in panic disorder

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Agoraphobic and panic disorder patients underwent 1-mg Dexamethasone Suppression Tests (DST) before, during, and after an 8-week trial of diazepam, alprazolam, or placebo. Previously described, never-ill controls underwent similar testing. At baseline, 21 of 82 (25.6%)panic disorder and 5 of 38 (13.2%) controls were nonsuppressors. This difference grew more marked with multiple testing over a 2-month period; 18 of 44 (40.9%) panic disorder patients were nonsuppressors on at least 1 of 3 tests compared with only 5 of 35 (14.3%) controls (p = 0.006). DST results were related to severity, but not to the presence or absence, of depressive syndromes. Control for plasma dexamethasone levels left highly significant differences in postdexamethasone cortisol across diagnostic groups. Neither DST results nor plasma dexamethasone levels changed in concert with clinical change, and type of treatment had little differential effect on these measures. Nor did DST results predict subsequent course when active treatment was extended by 6 months. However, DST results during the initial 8 weeks of treatment were strongly related to relapse when medications were tapered, even though this occurred 6 months after the last DST.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Avery DH
        • Osgood TB
        • Ashiki DM
        • Wilson LG
        • Kenny M
        • Dunner DL
        The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder or primary affective disorder.
        Am J Psychiatry. 1985; 142: 844-848
        • Berger M
        • Pirke KM
        • Krieg JC
        • VonZerssen D
        The effect of weight loss and inappropriate plasma dexamethasone levels on the DST.
        Psychiatry Res. 1985; 15: 351-360
        • Bridges M
        • Yeragani VK
        • Rainey JM
        • Pohl R
        Dexamethasone Suppression Test in patients with panic attacks.
        Biol Psychiatry. 1986; 21: 853-855
        • Bueno JA
        • Sabanes F
        • Gascon J
        • Gasto C
        • Salamero M
        Dexamethasone Suppression Test in patients with panic disorder and secondary depression.
        Arch Gen Psychiatry. 1984; 41: 723-734
        • Carr V
        • Morris H
        • Gilliland J
        The effect of serum dexamethasone concentrations in the DST.
        Biol Psychiatry. 1986; 21: 735-743
        • Carroll BJ
        Dexamethasone Suppression Test: A review of contemporary confusion.
        J Clin Psychiatry. 1985; 46: 13-24
        • Carroll BJ
        • Feinberg M
        • Greden JF
        • Tarika J
        • Albala AA
        • Haskett RF
        • James NM
        • Kronfol Z
        • Lohr N
        • Steiner M
        • deVigne JP
        • Young E
        A specific laboratory test for the diagnosis of melancholia.
        Arch Gen Psychiatry. 1981; 38: 15-22
        • Carson S
        • Halbreich U
        • Yeh C
        • Goldstein S
        Altered plasma dexamethasone and cortisol suppressibility in patients with panic disorder.
        Biol Psychiatry. 1988; 24: 56-62
        • Castellani S
        • Quillen M
        • Vaughan D
        • Hund M
        • Ho L
        • Ziegler M
        • LeVine W
        TSH and catecholamine response to TRH in panic disorder.
        Biol Psychiatry. 1988; 24: 87-90
        • Coryell W
        The use of laboratory tests in psychiatric diagnosis: The DST as an example.
        Psychiatr Dev. 1984; 3: 139-159
        • Coryell W
        Are serial Dexamethasone Suppression Tests useful in electroconvulsive therapy.
        J Affect Dis. 1986; 10: 59-66
        • Coryell W
        • Noyes R
        Placebo response in panic disorder.
        Am J Psychiatry. 1989; 145: 1138-1140
        • Coryell W
        • Schlesser MA
        Dexamethasone Suppression Test response in major depression: Stability across hospitalizations.
        Psychiatry Res. 1983; 8: 179-189
        • Coryell W
        • Zimmerman M
        HPA-axis abnormalities in psychiatrically well controls.
        Psychiatry Res. 1987; 20: 265-273
        • Coryell W
        • Smith R
        • Cook B
        • Moucharafeih S
        • Dunner F
        • House D
        Serial Dexamethasone Suppression Test results during antidepressant therapy: Relationship to diagnosis and clinical change.
        Psychiatry Res. 1983; 10: 165-174
        • Coryell W
        • Noyes R
        • Clancy J
        • Crowe R
        • Chaudhry D
        Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
        Psychiatry Res. 1985; 15: 301-311
        • Curtis GC
        • Cameron OG
        • Nesse RM
        The Dexamethasone Suppression Test in panic disorder and agoraphobia.
        Am J Psychiatry. 1982; 139: 1043-1046
        • Dackis CA
        • Bailey J
        • Pattash ALC
        • Stuckey RF
        • Gold MS
        Accuracy of Dexamethasone Suppression Test in alcoholics.
        Arch Gen Psychiatry. 1983; 40: 586-587
        • Endicott J
        • Spitzer RL
        A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia.
        Arch Gen Psychiatry. 1978; 35: 837-844
        • Faludi G
        • Kasko M
        • Perenyi A
        • Arato M
        • Frecska E
        The Dexamethasone Suppression Test in panic disorder and major depressive episodes.
        Biol Psychiatry. 1986; 21: 1008-1014
        • Fichter MN
        • Pirke KM
        DST, endocrines and loss of weight.
        Br J Psychiatry. 1985; 147: 94-95
        • Fogel BS
        • Satel SL
        Age, medical illness and the DST in depressed general hospital inpatients.
        J Clin Psychiatry. 1985; 46: 95-97
        • Georgatos A
        • Stokes PE
        • Hapworth WE
        • Kim OM
        • Fanelli C
        • Stoll PM
        • Sinaiko E
        • McCue RE
        The relationship of the Dexamethasone Suppression Test to subtypes of depression and to symptomatic severity in the elderly.
        J Affect Dis. 1986; 10: 51-57
        • Goldstein S
        • Halbreich U
        • Asnis G
        • Endicott J
        • Alvir J
        The hypothalamic-pituitary-adrenal system in panic disorder.
        Am J Psychiatry. 1987; 144: 1320-1323
        • Greden JF
        • DeVigne JP
        • Albala AA
        • Tarika J
        • Buttenheim M
        • Eiser A
        • Carroll BJ
        Serial Dexamethasone Suppression Test among rapidly cycling bipolar patients.
        Biol Psychiatry. 1982; 17: 455-462
        • Greenwald BS
        • Mathe AA
        • Mohs RC
        • Levy MI
        • Johns CA
        • Davis KL
        Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity and affective symptoms.
        Am J Psychiatry. 1986; 143: 442-446
        • Hamilton M
        The assessment of anxiety states by rating.
        Br J Med Psychol. 1959; 32: 50-55
        • Hamilton M
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
        • Holsboer F
        • Liebl R
        • Hofschuster E
        Repeated Dexamethasone Suppression Test during depressive illness.
        J Affect Dis. 1982; 4: 93-101
        • Holsboer F
        • Philipp M
        • Steiger A
        • Gerken A
        Multi-steroid analysis after DST in depressed patients—A controlled study.
        J Affect Dis. 1986; 10: 241-249
        • Hudson JI
        • Pope HG
        • Jonas JM
        • Laffer PS
        • Hudson MS
        • Melby JC
        Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
        Psychiatry Res. 1983; 8: 111-117
        • Hudson JI
        • Pope HG
        • Jonas JM
        • Yurgelun-Todd D
        Phenomenologie relationship of eating disorders to major affective disorder.
        Psychiatry Res. 1983; 9: 345-354
        • Hughes PL
        • Wells LA
        • Cunningham CJ
        The Dexamethasone Suppression Test in bulimia before and after successful treatment with desipramine.
        J Clin Psychiatry. 1986; 47: 515-517
        • Jones MT
        • Hillhouse EW
        • Burden J
        Effect of various putative neurotransmitters on the secretion of corticotropin-releasing-hormone from the rat hypothalamus in vitro—A model of the neurotransmitters involved.
        J Endocrinol. 1976; 69: 1-10
        • Kalogeras K
        • Khan I
        • Calogero A
        • Gallucci WT
        • Kling MA
        • Loriaux DL
        • Chrousos GP
        • Gold PW
        Effects of alprazolam, a potent benzodiazepine antidepressant on hypothalamic-pituitary-adrenal function.
        Clin Res. 1987; 35: 376
        • Lieberman JA
        • Brenner J
        • Lesser M
        • Coccaro E
        • Borenstein M
        • Kane JM
        Dexamethasone Suppression Tests in patients with panic disorder.
        Am J Psychiatry. 1983; 140: 917-919
        • Loosen PT
        • Prange AJ
        Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: A review.
        Am J Psychiatry. 1982; 139: 405-416
        • Lopez AL
        • Kathol RG
        • Noyes R
        Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
        Psychoneuroendocrinology. 1989; (in press).
        • Makara GB
        • Stark E
        Effect of gamma-aminobutyric acid (GABA) antagonist drugs on ACTH release.
        Neuroendocrinology. 1974; 16: 178-190
        • Meador-Wodruff JH
        • Haskett RF
        • Grunhaus L
        • Akil H
        • Watson SJ
        • Greden JF
        Post-dexamethasone plasma cortisol and beta-endorphin levels in depression: Relationship to severity of illness.
        Biol Psychiatry. 1987; 22: 1137-1150
        • Noyes R
        • Crow RR
        • Harris EL
        • Hamra BJ
        • McChesney CM
        • Chaudhry DR
        Relationship etween panic disorder and agoraphobia: A family study.
        Arch Gen Psychiatry. 1986; 43: 227-232
        • Peterson GA
        • Ballenger JC
        • Cox DP
        • Hucek A
        • Lydiard RB
        • Laraia MT
        • Trockman C
        The Dexamethasone Suppression Test in agoraphobia.
        J Clin Psychopharmacol. 1985; 5: 100-102
        • Roy-Byrne PP
        • Uhde TW
        • Post RM
        • Gallucci W
        • Chrousos GP
        • Gold PW
        The corticotropin releasing hormone stimulation test in patients with panic disorder.
        Am J Psychiatry. 1986; 143: 896-899
        • Roy-Byrne PP
        • Uhde TW
        • Rubinow DR
        • Post RM
        Reduced TSH and prolactin responses to TRH in patients with panic disorder.
        Am J Psychiatry. 1986; 143: 503-507
        • Schapira K
        • Roth M
        • Kerr TA
        • Gurney C
        Prognosis of affective disorders: The differentiation of anxiety states from depressive illnesses.
        Br J Psychiatry. 1972; 121: 175-181
        • Sheehan DV
        • Coaycomb JB
        • Surman OS
        • Baer L
        • Coleman J
        • Gelles L
        Panic attacks and the Dexamethasone Suppression Test.
        Am J Psychiatry. 1983; 140: 1063-1064
        • Spitzer RL
        • Endicott J
        • Robins E
        Research Diagnostic Criteria.
        ed 3. Biometrics Research, New York State Department of Mental Hygiene, New York1978
        • Spitzer RL
        • William JBW
        Structured Clinical Interview for DSM-III—Upjohn Version.
        Biometrics Research Department, New York State Psychiatric Institute, New York1983 (SCID-UP 3/15/83)
        • Stangl D
        • Pfohl B
        • Zimmerman M
        • Bowers W
        • Corenthal C
        A structured interview for the DSM-III personality disorders.
        Arch Gen Psychiatry. 1985; 42: 591-596
        • Tallman JF
        • Paul SM
        • Skolnick P
        • Gallager DW
        Receptors for the age of anxiety: Pharmacology of the benzodiazepines.
        Science. 1980; 207: 274-281
        • Torgersan S
        Genetic factors in anxiety disorder.
        Arch Gen Psychiatry. 1983; 40: 1085-1089
        • Whiteford HA
        • Evans L
        Agoraphobia and the Dexamethasone Suppression Test: Atypical depression?.
        Austral NZ J Psychiatry. 1984; 18: 374-377
        • Zimmerman M
        • Coryell W
        The Dexamethasone Suppression Test in healthy controls.
        Psychoneuroendocrinology. 1987; 12: 245-251